We’re excited that the Billev Pharma East team will be attending the 23rd Regulatory Affairs Conference in Amsterdam on February 27–28, 2025!

As the regulatory industry reaches a turning point, staying ahead is no longer an option—it’s a necessity.

With the ongoing revision of pharmaceutical legislation, changes in the Variations Regulation, advancements in digitalization, environmental risk assessment, artificial intelligence, and big data, this conference presents a timely and unmissable opportunity to stay informed about these developments and their impact on future regulatory operations.

That’s why we are thrilled to contribute to the conversation, network with key industry leaders shaping the future of compliance, and exchange first-hand insights with top regulatory experts.

Even more exciting, our own Katja Pecjak Reven will be speaking at Session 6, delving into pharmaceutical Product Information (PI) and covering the following key topics:

📜 The latest proposals to amend pharmaceutical legislation related to product information.
⚖️ The potential impact of these changes on company operations.
📝 A discussion on the new QRD template and opportunities for further refinement.
💻 The role of the electronic PI (ePI) project and next steps toward a patient-centric approach.

For more information, the full agenda, and registration details, visit:
👉 https://www.medicinesforeurope.com/events/rac25/

If you’re attending, we would love to meet you! Visit us at our exhibition booth or connect with us during two full days of insightful discussions.

Let’s shape the future of regulatory affairs together!